Trial Profile
Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2019
Price :
$35
*
At a glance
- Drugs Zafirlukast (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 11 Mar 2019 Status changed from recruiting to discontinued.
- 25 Jul 2017 Planned primary completion date changed from 1 May 2017 to 1 Jan 2019.
- 25 Jul 2017 Status changed from not yet recruiting to recruiting.